Dr. Sunil David will join the Department of Medicinal Chemistry in August. He is known for his work in adjuvant vaccine
development, infectious disease, immunology, and inflammatory disease
processes. Researchers from his group at the University of Kansas will join him in his new lab in the Cancer & Cardiovascular Research Building.